MetLife Investment Management’s Hims & Hers Health HIMS Stock Holding History

MetLife Investment Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.78M	Buy	224,462 +13,145	+6%	+$353K	0.04%	461
2026 Q1	$4.39M	Sell	211,317 -159	-0.1%	-$3.76K	0.02%	668
2025 Q4	$6.87M	Sell	211,476 -3,159	-1%	-$135K	0.03%	482
2025 Q3	$12.2M	Sell	214,635 -910	-0.4%	-$46.6K	0.06%	300
2025 Q2	$10.7M	Sell	215,545 -208	-0.1%	-$9.4K	0.06%	294
2025 Q1	$6.38M	Buy	215,753 +100,957	+88%	+$3.75M	0.03%	500
2024 Q4	$2.78M	Buy	114,796 +5,052	+5%	+$125K	0.02%	880
2024 Q3	$2.02M	Hold	109,744	–	–	0.01%	1009
2024 Q2	$2.22M	Buy	109,744 +45,852	+72%	+$763K	0.01%	923
2024 Q1	$988K	Sell	63,892 -3,155	-5%	-$35.6K	0.01%	1306
2023 Q4	$597K	Hold	67,047	–	–	﹤0.01%	1586
2023 Q3	$422K	Hold	67,047	–	–	﹤0.01%	1732
2023 Q2	$630K	Hold	67,047	–	–	﹤0.01%	1546
2023 Q1	$665K	Hold	67,047	–	–	﹤0.01%	1464
2022 Q4	$430K	Hold	67,047	–	–	﹤0.01%	1738
2022 Q3	$374K	Hold	67,047	–	–	﹤0.01%	1846
2022 Q2	$304K	Buy	+67,047	New	+$286K	﹤0.01%	2015

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MetLife Investment Management's HIMS Position: Q2 2026 in Review

MetLife Investment Management increased its Hims & Hers Health (HIMS) stake by 6.2% in Q2 2026, buying an estimated $353K and bringing the position to 224,462 shares worth $7.78M. The position accounts for 0.04% of the portfolio, ranked #461.

MetLife Investment Management first reported a position in HIMS in Q2 2022 and has held it in 17 quarters since. The position peaked at $12.2M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

MetLife Investment Management held 224,462 shares of Hims & Hers Health worth $7.78M as of Q2 2026.
MetLife Investment Management bought 13,145 Hims & Hers Health shares in Q2 2026, an estimated $353K.
Hims & Hers Health made up 0.04% of MetLife Investment Management's portfolio in Q2 2026, its #461 holding.
MetLife Investment Management first reported a position in Hims & Hers Health in Q2 2022 and has held it in 17 quarters since.
MetLife Investment Management's Hims & Hers Health position peaked at $12.2M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.